Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR) Posts Basic Consolidated EPS Of $-2.1058

0

Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR)managed to report annual basic consolidated EPS of $-2.1058, which was for the year ended2015-12-31.The company reported basic consolidated EPS of $-2.1058 for the quarter ended 2015-12-31.

EPS from continuing operations

If you look at the performance of the company’s continuing operations, you see that EPS generated from such operations was {EPS_BASIC_CONT_OPER:1541}} for the year ended 2015-12-31. As for the quarter ended 2015-12-31, continuing operations produced EPS of $-0.7886.

EPS contribution from parent

Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR) received of $-2.1058 EPS boost from the parent company for the annual period ended

For the year ended 2015-12-31, the parent of Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR) contributed EPS of $-2.1058 to the company’s bottom-line. But for the quarter ended 2015-12-31, EPS boost from the parent was cited as $-2.1058.

What About Basic net EPS

The basic net EPS that Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR) reported for the year ended 2015-12-31 stood at $-2.11. For the quarter ended 2015-12-31, the company posted basic net EPS of $-2.11.

What About Consolidated Diluted EPS?

Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR)’s consolidated diluted EPS for the year ended 2015-12-31 was reported as $-2.1058. For the quarter ended 2015-12-31 the metric was$-2.1058.

Basic diluted EPS

The company managed to register diluted EPS from continuing operation of at $-2.1058 for the yearended 2015-12-31. But diluted EPS from continuing operations for the quarter ended 2015-12-31 came in at $-2.1058.

Net diluted EPS

Net diluted EPS posted by Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR) for the year ended 2015-12-31 was $-2.11. On quarterly basis, net diluted EPS for the quarter ended 2015-12-31 was reported as $-2.11.

What portion of diluted EPS came from parent?

For the annual period ended 2015-12-31, the parent company of Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR) said that it parent company boosted its diluted EPS by$-2.1058 in the year ended 2015-12-31. For the quarter ended 2015-12-31, the parent company’s contribution to diluted EPS was $-2.1058.

The company reported net basic EPS of $-2.11 for the year ended 2015-12-31 and net basic EPS of $-2.11 for the quarter ended 2015-12-31.

The number of Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR)’s basic shares outstanding at the end of the annual period ended 2015-12-31 was 40.587. That compares with 40.587 basic shares outstanding for the quarter ended 2015-12-31.

Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR) had 40.587 diluted shares outstanding at the end of the annual period ended 2015-12-31. But for the quarter ended 2015-12-31, diluted outstanding shares were 40.587.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 23 times, 1 visits today)